Introduction
Adverse reactions to food are among the most common complaints in children. However, only 2-4% of these reactions can be attributed to reproducible, IgE-mediated food allergies 1) . Atopic dermatitis (AD) is commonly associated with a food allergy 2) . Gastrointestinal and respiratory symptoms may also be caused by a food allergy.
The diagnostic work-up of a suspected food allergy includes the patient's history, a skin-prick test (SPT) 3) , measurement of food-indications, the practical performance (including preparation and dosing), and the interpretation of OFCs.
Indications for OFCs
An OFC should be performed for establishment or exclusion of a diagnosis, for scientific purposes in clinical trials, or for the determination of the threshold value or the allergenicity of foods. Fig.  1 provides an algorithm for proceeding from the suspicion of foodrelated symptoms to the final decision for recommending a specific therapeutic elimination diet. The process includes the measurement of specific IgE levels or an SPT in the decision-making process 6, 7) . Diagnostic decision points for specific IgE, with a 90% predictive probability for 4 major food allergens, have been described by Sampson et al. (Table 1) 4)
. However, predictive decision points vary remarkably among authors and the studied population 8) . Therefore, decision points must be studied for each food allergen in the target population. These efforts may help avoid unnecessary OFCs.
Types of OFC
There has been a debate about whether OFCs should be done in an open or double-blind fashion. In an open OFC, the food is given in its natural form. For a single-blind OFC, the food or placebo is given in a vehicle that disguises the appearance and the taste of the food. The patient is unaware of the nature of the food given, whereas staff involved in the procedure have this information. For DBPCFCs, none of the parties involved is aware of the composition of the product. Placebo challenges are indicated if day-to-day variation plays a major role in symptoms, for example in children with AD, or in cases where there are subjective symptoms such as abdominal discomfort, a burning sensation on the tongue, or palpitations 9, 10) . Common clinical indications for OFC and the corresponding procedures are shown in Table 2 10)
. Although DBPCFC is generally the preferred scientific research protocol, open challenge may be indicated in infants and children younger than 3 years of age, according to a review by the European Academy of Allergology and Clinical Immunology 11) .
Preparation for OFC
There are several issues to be considered prior to an OFC in patients. These can be divided into patient-related and procedurerelated parameters (Table 3) 11) .
Settings
The OFC should be designed and carried out by experienced health care professionals in a facility where the challenge can be closely monitored and measures for the treatment of potential life-threatening reactions are available. Hospital admission or, occasionally, the intensive care unit, may be necessary in certain cases 12) . The timing, type, and severity of expected symptoms may influence the selection of the OFC location 13) .
Food preparation
Food for an open OFC can be brought from home by the patient or parent, whereas for a blind OFC, the test material should be provided by a physician to ensure proper masking. The food should be prepared without cross-contamination or contact with other foods to which the patient may react 13) . The procedure must be adjusted according to the stability and allergenicity of the food in question 14) . Thermal processing, heating, and cooking change protein conformation and may result in a change in allergenicity 15) . Thus, tolerance to the cooked versions of many foods does not predict tolerance to less cooked forms.
The original OFC vehicle used for blinding was an opaque capsule. However, these capsules have considerable limitations: difficulty in administering adequate quantities of food, possible destruction of allergenicity, probable difficulty in swallowing, bypass of early oral symptoms, and delayed absorption 13) . Only in cases where there is a suspected reaction to additives is masking in gelatin capsules recommended 11) . For most OFCs in young children, infant formulas and applesauce are convenient vehicles 11, 13) .
Dosing schedule for OFC

Total dose for OFCs
The total dose, that is, the maximal amount of the substance administered, should generally be the normal daily intake in a serving of the food in question, adjusted for the age of the patient. In 1 approach, the total amount administered during a gradually escalating OFC equals 8-10 g of the dry food, 16-26 g of meat or fish, and 100 mL of the wet food 16) . The challenge food is mixed with the vehicle and administered in gradually increasing increments every 15 minutes. This time interval is preferred because most acute reactions occur within 15 minutes; however, the dosing interval must be adjusted on the basis of a patient's history 11, 17) . If the patient is expected to tolerate the tested food, an age-appropriated serving of food in its natural form may be served in small potions over a period of 30 to 60 minutes (Table 4) 13) .
Initial challenge dose
The starting dose should be evaluated based on the patient's history and available data from the literature (Table 5) 11) . According to published data, 5% of patients react to less than 1mg of peanut, whereas 15% of milk allergic patients react to less than 5 mL of cow's milk 18, 19) . Attempts to predict the outcome of OFCs for egg, through specific IgE assays or SPT end-point titration, have also been made 20) . If possible, the initial OFC dose should be lower than the expected threshold dose, for example, the amount that the patient developed a reaction to previously. In an open OFC performed according to a simplified protocol, the entire serving of challenge food may be divided into 3 equal portions 13) .
Interpretation of OFC
Despite controlled conditions, it is sometimes difficult to determine whether clinical symptoms are sufficiently clear to make a decision. Niggemann et al. proposed a decision tree for various situations during an OFC procedure, which is reproduced in Fig. 2 7)
. Different approaches should be taken for patients presenting classical allergic symptoms with objective signs of a reaction on OFC, and for patients presenting subjective symptoms only. In a classical type I allergy with objectively measurable signs, reactions to a placebo are relatively rare and a procedure using one active OFC and one placebo is sufficient 21) . In contrast, the frequency of reactions to placebo seen in patients presenting subjective symptoms is higher. In these cases, repeated OFC is necessary 22) . Where an OFC gives a positive result, food elimination may be continued under nutritional supervision. If a negative OFC result is obtained, it is important to ensure that the quantity tolerated by the patient on the day of test corresponds to the amount likely to be eaten during a normal meal.
Risks of OFCs
OFCs should be performed in a setting suitable for the handling of any side effects, including anaphylaxis. This covers the location, the presence of trained personnel, monitoring facilities, and suitable equipment for medical intervention. Intravenous access is a basic safety measure, but complications related to such procedures have been reported, which ranged from local irritation through to thrombophlebitis of the hand or arm 23) .
It is important to bear in mind the possibility of anaphylactic reaction and to recognize the initial symptoms. Such awareness of symptoms may prevent progression to a more serious clinical situation. H1 antihistamines can mask the early signs of anaphylaxis, and patients with asthma have a higher risk of anaphylaxis 10) .
Conclusion
The OFC is a valuable tool in the diagnosis and management of children with suspected food allergy. In most cases, OFCs can be performed in a controlled manner without risk. Efforts to standardize OFCs, so that they enable physicians to reach better decisions and avoid unnecessary elimination diets, have been made by The Korean Academy of Pediatric Allergy and Respiratory Disease. The actual starting dose must always be considered in the actual patient. 
